<?xml version="1.0" encoding="UTF-8"?>
<svg height="769.854" width="553.4614941935483" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <text x="70.276,75.661,78.484,81.484,82.984,87.524,89.71,92.511,94.179,95.679,99.055,101.822,103.652,106.661,108.329,109.829,114.368,116.554,119.355,121.023,122.523,126.551,128.449,130.447,131.947,136.043,139.16,141.949,144.751,146.507,148.007,149.507,152.597,155.416,158.291,161.291,162.791,168.248,171.122,173.12,174.62,177.449,179.234,182.331,185.331,186.831,188.766,191.611,193.563,195.147,197.843,200.638,203.329,206.251,208.073,211.124,214.139,215.639,217.139,218.639,220.139,221.639,223.139,224.639,226.139,227.639,229.139,230.639,232.139,233.639,235.139,236.639,238.139,239.639,241.139,242.639,244.139,245.639,247.139,248.639,250.139,251.639,253.139,254.639,256.139,257.639,259.139,260.639,262.139,263.639,265.139,266.639,268.139,269.639,271.139,272.639,274.139,275.639,277.139,278.639,280.139,281.639,283.139,284.639,286.139,287.639,289.139,290.639,292.139,293.639,295.139,296.639,298.139,299.639,301.139,302.639,304.139,305.639,307.139,308.639,310.139,311.639,313.139,314.639,316.139,318.367,323.148,326.173,327.952,330.821,333.891,335.753,338.087,339.587,341.48,344.48,345.98,349.105,351.872,353.753,355.468,358.297,361.366,363.228,365.562,367.062,371.594,373.313,375.183,378.183,379.683,382.787,384.972,387.774,389.442,390.942,395.762,398.632,401.849,403.665,405.693,408.519,410.97,412.873,415.64,417.521,419.23,422.336,425.515,427.849,429.349,432.334,434.332,435.832,438.604,441.7,443.53,446.571,448.458,453.398,458.14,461.392,464.492,467.156,468.656,471.76,473.758,475.258,479.999,483.116,485.921,489.157,491.395,494.191,497.287,499.189,502.059,505.16,507.983,511.07,514.257,516.591,518.091,521.292,523.083,525.539,528.356,531.204,533.659,536.484" y="44.424999999999955" svg_rhmargin="538.818" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:6.0px;font-style:NORMAL;font-weight:normal;">Med Oral Patol Oral Cir Bucal. 2019 Mar 1;24 (2):e217-30. Implants in patients with oral manifestations of autoimmune or muco-cutaneous diseases</text>
  <text x="296.941,300.493,304.493,308.493" y="759.854" svg_rhmargin="312.493" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:8.0px;font-style:NORMAL;font-weight:normal;">e222</text>
  <text x="76.991,81.469,85.969,88.219,92.386,96.976,101.669,104.128,106.843,109.286,113.831,118.451,122.542,125.044" y="95.46799999999996" svg_rhmargin="127.294" style="fill:#000000;font-family:EHOOBT+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">23 additional </text>
  <text svg_rhmargin="106.476" x="76.991,81.188,85.808,89.898,92.373,96.925,100.399,102.975,106.476" y="95.46799999999996" style="fill:#000000;font-family:EHOOBT+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">analysis </text>
  <text x="290.362,295.398,299.524,303.52,305.77,310.718,314.781,319.198,321.667,325.663,327.913,332.176,334.426,503.953,508.606,511.927" y="95.46799999999996" svg_rhmargin="516.427" style="fill:#000000;font-family:EHOOBT+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">See Table 3. 5-6</text>
  <text x="76.991,81.516,86.016,88.266,91.868,96.634,103.943,111.064,115.271,118.666,123.166,125.416,129.766,132.763" y="120.50800000000004" svg_rhmargin="135.013" style="fill:#000000;font-family:EHOOBT+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">24 summary of </text>
  <text svg_rhmargin="109.505" x="76.991,81.022,85.71,88.179,92.745,96.878,101.427,105.509,109.505" y="120.50800000000004" style="fill:#000000;font-family:EHOOBT+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">evidence </text>
  <text x="154.57,161.277,165.777,168.027,172.582,176.744,180.222,182.797,186.298,188.548,192.898,195.895,198.145,204.538,208.654,212.871,216.967,220.206,224.237,228.925,231.394,235.96,240.093,244.642,248.723,252.719,254.969,259.481,264.054,268.47,271.122,273.586,277.655,281.689,284.405,286.848,291.393,296.052,299.553,301.803,308.492,310.95,313.65,318.15,320.4,324.396,326.646,331.354,333.784,338.499,342.999,345.249,348.541,351.116,354.662,359.162,361.412,365.762,368.759,371.009,375.48,378.016,382.179,385.781,388.031,390.281,393.006,400.064,404.48,407.033,411.229,415.716,418.218,420.468,424.068,428.851,432.234,436.922,439.385,443.899,447.988,450.49,452.74,455.908,459.942,462.585,466.714,470.215" y="120.50800000000004" svg_rhmargin="472.465" style="fill:#000000;font-family:EHOOBT+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">On basis of weak-evidence publications with a high risk of bias, implant survival rates </text>
  <text x="150.117,154.468,157.465,159.715,164.289,168.324,171.039,173.491,177.625,182.111,184.797,188.298,190.548,197.237,199.696,202.394,206.894,209.144,213.581,219.08,223.508,225.758,228.008,232.861,236.894,239.144,241.394,246.948,252.978,255.228,257.478,262.343,264.764,269.839,272.089,274.339,277.848,283.388,288.887,291.137,295.676,298.673,300.923,304.471,309.521,313.517,315.767,319.971,323.058,327.054,329.304,333.398,337.929,344.987,349.562,353.767,356.936,361.001,365.417,367.886,371.882,374.132,376.764,381.264,383.514,386.212,390.731,395.306,398.874,402.87,405.12,409.469,412.466,414.716,419.245,423.36,427.45,429.909,432.607,437.061,441.561,443.811,448.386,452.421,455.136,457.588,461.721,466.208,468.894,472.423,474.673" y="131.308" svg_rhmargin="476.923" style="fill:#000000;font-family:EHOOBT+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">of patients with oLp, Pe, EB, SjS, sLE or sSc are comparable to those of healthy patients. </text>
  <text x="217.618,225.574,229.689,233.886,238.386,240.636,243.53,247.92,250.562,253.022,257.415,263.788,266.861,271.43,275.93,278.18,282.803,286.944,290.237,292.679,297.283,301.972,305.473,307.723,314.117,318.259,321.346,325.342,327.592,331.6,335.972,340.054,344.179,348.303,352.996,355.728,360.241,364.741,366.991,371.23,375.73,377.98,385.01,389.555,394.041,396.739,401.39,404.919" y="142.10799999999995" svg_rhmargin="407.169" style="fill:#000000;font-family:EHOOBT+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">Mean follow-up periods were exceeding 32 months.</text>
  <text x="151.706,156.674,161.457,164.836,167.534,172.062,176.203,179.2,181.45,185.519,189.681,193.25,197.246,199.496,203.057,205.897,210.47,215.162,217.615,221.743,225.244,227.494,232.036,235.033,237.283,241.861,244.926,249.501,253.106,257.729,261.866,265.948,268.664,271.127,275.521,279.517,281.767,285.329,288.169,292.742,297.435,299.887,304.015,307.516,309.766,313.292,317.811,322.324,326.991,329.451,333.951,336.201,339.288,343.459,348.081,352.622,355.999,358.501,360.751,365.263,369.789,372.44,376.535,381.067,388.104,392.232,395.733,397.983,400.879,405.269,407.912,410.372,414.765,421.452,424.186,428.699,433.199,435.449,437.909,442.454,446.967,451.451,455.593,458.59,460.84,465.34,470.084" y="152.90800000000002" svg_rhmargin="473.081" style="fill:#000000;font-family:EHOOBT+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">Further case studies or prospective studies should report outcomes following longer ob-</text>
  <text x="149.217,152.786,156.927,160.309,164.822,168.857,171.572,174.015,178.56,183.06,185.31,189.932,194.074,197.366,199.809,204.412,209.101,212.602,214.852,221.539,223.999,226.697,231.197,233.447,237.541,242.087,246.746,250.223,252.693,257.258,261.4,264.569,268.603,271.319,273.761,278.306,282.806,285.056,289.407,292.404,294.654,298.749,303.261,308.045,311.217,314.785,318.781,321.031,325.381,328.378,330.628,333.326,337.854,341.85,344.1,348.792,351.366,354.935,359.05,363.213,366.781,370.91,374.439,376.689,378.939,386.858,391.525,393.984,396.699,399.165,403.246,407.38,411.866,414.681,417.973,420.438,424.434,426.684,431.405,435.439,438.19,442.186,444.436,448.63,453.251,457.341,459.817,464.369,467.937,472.066,475.568" y="163.70799999999997" svg_rhmargin="477.818" style="fill:#000000;font-family:EHOOBT+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">servation periods with consideration of course of the diseases. Multicentric data analyses </text>
  <text x="147.278,154.497,156.927,161.642,166.12,168.622,170.872,175.475,179.471,181.721,185.717,187.967,192.652,195.187,199.252,203.668,206.137,210.133,212.383,219.421,223.485,226.184,230.703,235.307,239.807,242.057,244.69,249.19,251.44,256.009,260.107,262.84,267.34,269.59,276.619,281.159,284.246,288.242,290.492,295.214,299.248,301.998,305.994,308.244,311.33,315.319,319.887,324.094,327.142,331.834,334.567,339.08,343.58,345.83,348.53,353.057,357.053,359.303,363.366,367.969,372.354,376.748,380.744,382.994,390.029,394.163,398.65,401.365,403.808,408.353,412.889,417.013,421.513,423.763,428.456,431.031,434.599,438.714,442.877,446.445,450.574,454.176,456.426,458.676,462.154,464.886,469.436,473.517,477.513" y="174.50800000000004" svg_rhmargin="479.763" style="fill:#000000;font-family:EHOOBT+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">might be a viable method to gain more data regarding the above mentioned diseases, since </text>
  <text svg_rhmargin="379.522" x="245.266,247.964,252.492,256.488,258.738,263.316,266.403,270.433,274.946,279.037,281.506,285.639,290.188,294.27,298.266,300.516,304.865,307.862,310.112,312.81,317.338,321.334,323.584,328.275,330.851,334.419,338.534,342.697,346.265,350.394,353.895,356.145,358.721,362.222,364.472,366.934,371.328,377.272,379.522" y="120.50800000000004" style="fill:#000000;font-family:EHOOBT+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">the prevalence of the diseases is low. </text>
  <text x="506.014,509.866" y="120.50800000000004" svg_rhmargin="514.366" style="fill:#000000;font-family:EHOOBT+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">11</text>
  <text x="76.991,81.457,85.957,88.207,90.858,93.584,100.802,103.26,106.01,110.045,112.763,115.206,119.75,124.41,127.911,152.154,157.059,159.793,164.341,168.423,172.419,174.669,181.696,186.271,189.834,192.336,194.586,198.935,201.932,204.182,206.914,211.463,215.356,217.854,222.426,226.992,231.117,235.617,237.867,242.379,246.952,251.369,254.02,256.484,260.553,264.587,267.303,269.746,274.291,278.95,282.451,284.701,291.096,295.237,298.324,302.32,304.57,307.029,311.423,317.795,320.743,323.213,327.243,331.637,335.575,338.077,340.327,344.355,349.043,351.513,356.078,360.211,364.76,368.842,372.838,375.088,379.155,383.318,386.886,390.882,393.132,396.218,400.39,405.011,409.552,412.93,415.615,419.116,421.366,425.909,428.906,431.156,435.224,439.387,442.955,446.951,449.201,452.768,456.909,460.201,462.653,466.782,470.384,472.634" y="199.548" svg_rhmargin="474.884" style="fill:#000000;font-family:EHOOBT+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">25 limitations Since most of included publications were low-level evidence case reports or case series, </text>
  <text x="148.867,153.063,157.59,162.09,164.34,171.378,175.492,179.689,184.189,186.439,189.334,193.723,196.365,198.826,203.22,209.592,212.664,217.234,221.734,223.984,230.496,234.658,238.16,240.41,244.48,248.57,251.025,255.107,259.775,262.327,266.361,269.004,273.128,277.628,279.878,284.483,288.548,291.362,297.756,301.88,306.014,310.514,312.764,317.003,321.503,323.753,327.949,332.476,336.976,339.226,343.459,347.959,350.209,357.238,361.783,366.269,368.967,373.618,377.22,379.47,381.72,385.815,390.36,394.908,398.801,401.303,405.975,409.451,411.895,416.44,421.099,424.6,426.85,430.92,435.116,439.616,441.866,446.47,450.466,452.716,457.516,460.685,464.634,471.424,475.924" y="210.34799999999996" svg_rhmargin="478.174" style="fill:#000000;font-family:EHOOBT+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">and mean follow-up was calculated between 32 and 45 months, conclusions can be drawn </text>
  <text x="153.036,157.581,162.081,164.331,168.327,170.577,174.969,179.11,182.505,187.005,189.255,191.906,194.632,201.852,204.31,206.954,211.077,215.577,217.827,221.859,226.547,229.015,233.581,237.714,242.262,246.345,250.56,253.508,255.978,260.008,264.402,268.339,270.855,273.105,275.355,277.605,283.896,286.471,290.017,294.517,296.767,301.118,304.115,306.365,310.399,313.201,316.015,319.307,321.766,324.482,326.925,331.47,335.97,338.22,342.691,345.226,349.39,352.891,355.141,359.338,363.865,368.365,370.615,373.702,377.875,382.496,387.037,390.414,393.13,395.862,400.375,404.875,407.125,411.597,414.133,418.295,421.796,424.046,428.254,431.341,435.337,437.587,441.187,445.756,450.363,454.985,459.56,463.128,467.252,471.752" y="221.14800000000002" svg_rhmargin="474.002" style="fill:#000000;font-family:EHOOBT+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">on a very limited evidence-level. Risk of attrition bias and reporting bias are supposed </text>
  <text x="303.054,307.765,310.195,314.909,319.484" y="231.94799999999998" svg_rhmargin="321.734" style="fill:#000000;font-family:EHOOBT+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">high.</text>
  <text x="76.991,81.465,85.965,88.215,92.309,96.854,101.399,105.292,107.79,112.462,115.939,118.382,122.927,127.586,131.087,150.399,158.863,161.322,164.02,168.731,171.463,175.963,178.213,180.912,185.44,189.436,191.686,194.337,197.061,204.281,206.74,209.426,212.927,215.177,219.529,222.525,224.775,227.236,231.63,238.003,240.951,243.42,247.45,251.844,255.781,258.283,260.533,264.563,269.251,271.72,276.285,280.418,284.967,289.049,293.045,295.295,299.806,304.379,308.795,311.447,313.912,317.98,322.014,324.73,327.173,331.718,336.377,339.878,342.128,346.326,350.947,355.036,357.513,362.065,365.633,369.757,374.257,376.507,380.703,385.23,389.73,391.98,394.632,397.357,404.577,407.036,409.679,413.803,418.303,420.553,427.59,431.705,435.901,440.401,442.651,447.151,451.726,455.294,459.435,462.819,467.332,471.392" y="246.188" svg_rhmargin="474.389" style="fill:#000000;font-family:EHOOBT+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">26 conclusions Within the limits of low-level evidence publications analysed and limited mean observa-</text>
  <text x="154.428,157.143,159.586,164.131,168.752,172.842,175.344,177.594,182.214,186.356,189.648,192.091,196.694,201.383,204.986,207.236,209.486,212.21,219.269,223.685,226.238,230.434,234.92,237.342,240.432,245.009,248.074,252.649,256.211,258.91,263.438,267.503,270.218,272.683,276.679,278.929,281.743,284.83,288.944,292.979,295.784,302.821,306.955,311.442,313.944,316.194,320.542,323.539,325.789,330.364,334.399,337.114,339.566,343.699,348.186,350.872,354.373,356.623,363.311,365.771,368.469,372.969,375.219,379.656,385.155,389.582,391.832,394.082,398.936,402.969,405.219,407.469,413.023,419.053,421.303,423.553,428.093,431.09,433.34,438.205,440.627,445.631,447.881,451.45,455.575,459.7,466.86,470.361" y="256.98800000000006" svg_rhmargin="472.611" style="fill:#000000;font-family:EHOOBT+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">tional periods, implant-prosthetic treatment of patients with oLp, Pe, EB, or SjS seems </text>
  <text x="150.876,153.51,158.01,160.26,164.864,168.86,171.11,175.106,177.356,181.931,184.996,189.528,196.748,199.323,202.801,205.533,210.047,214.547,216.797,219.611,222.698,226.814,230.848,233.654,240.691,244.824,249.31,251.812,254.062,258.618,263.146,265.861,268.304,272.849,277.431,279.681,281.931,286.662,291.202,294.199,296.449,299.174,306.232,310.649,313.201,317.397,321.883,324.305,327.395,331.972,335.038,339.613,343.176,345.874,350.402,354.466,357.182,359.647,363.643,365.893,368.979,373.013,377.625,381.689,386.16,388.786,391.437,393.896,396.647,400.68,403.396,405.839,410.384,414.884,417.134,421.485,424.482,426.732,431.307,435.34,438.057,440.508,444.641,449.128,451.814,455.315,457.565,464.254,466.713,469.412,473.912" y="267.788" svg_rhmargin="476.162" style="fill:#000000;font-family:EHOOBT+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">to be a promising treatment option. For implant-prosthetic rehabilitation of patients with </text>
  <text x="150.588,155.441,159.437,161.687,165.883,170.41,174.91,177.16,180.669,186.21,191.709,193.959,198.484,202.984,205.234,209.328,213.873,218.422,222.315,224.813,229.485,232.962,235.405,239.95,244.609,248.11,250.36,254.43,258.627,263.127,265.377,269.981,273.977,276.227,281.026,284.195,288.145,294.935,299.435,301.685,306.267,310.815,314.811,317.061,319.694,324.194,326.444,328.996,333.142,337.125,341.625,343.875,348.226,351.223,353.473,357.074,361.729,365.045,370.019,374.053,376.505,380.638,385.125,387.627,389.877,393.768,396.42,399.152,403.871,406.336,410.404,414.495,416.997,419.247,423.968,428.002,430.752,434.88,437.13,439.38,445.821,450.215,456.608,460.638,465.032,469.174,471.951,474.201" y="278.58799999999997" svg_rhmargin="476.451" style="fill:#000000;font-family:CRUCZX+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">Pe and sLE no conclusions can be drawn due to lack of sufficient clinical data. However, </text>
  <text x="155.186,158.0,161.087,165.203,169.236,172.043,179.08,183.212,187.699,190.201,192.451,197.262,201.938,204.407,208.972,212.91,215.561,218.294,222.83,226.959,230.46,232.71,235.798,239.786,244.356,248.561,251.61,256.302,259.036,263.549,268.049,270.299,274.827,278.942,283.032,285.491,288.189,292.643,297.143,299.393,303.968,308.003,310.718,313.17,317.303,321.79,324.476,327.977,330.227,333.752,338.272,342.783,347.452,349.911,354.411,356.661,361.266,365.262,367.512,371.073,373.887,377.18,379.645,383.726,386.317,388.794,393.294,395.544,398.439,402.828,405.47,407.93,412.324,418.717,422.842,427.46,429.71,431.96,439.903,444.444,447.531,451.656,456.04,460.434,464.575,467.352,469.602" y="289.388" svg_rhmargin="471.852" style="fill:#000000;font-family:EHOOBT+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">treatment guidelines regarding healthy patients should be strictly followed. Moreover, </text>
  <text svg_rhmargin="471.117" x="153.674,156.988,160.075,164.199,168.781,173.33,177.463,181.949,184.451,186.701,189.787,193.925,197.993,202.083,204.725,207.227,209.477,212.051,215.552,217.802,220.891,225.029,229.124,233.654,240.965,248.002,252.136,256.663,261.228,265.352,269.852,272.102,274.835,279.335,281.585,286.159,290.194,292.909,295.362,299.495,303.981,306.667,310.168,312.418,316.497,319.705,322.626,326.763,330.845,333.488,337.611,342.111,344.361,351.049,353.508,356.207,360.707,362.957,367.394,372.893,377.32,379.57,381.82,386.686,389.107,394.181,396.431,398.681,404.235,410.265,412.515,414.765,419.762,424.812,428.808,431.058,433.308,438.161,442.157,444.407,448.946,451.943,454.193,457.702,463.242,468.867,471.117" y="246.188" style="fill:#000000;font-family:CRUCZX+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">frequent recall is recommended in patients affected with oLp, SjS, EB, SSc, Pe or sLE. </text>
  <text x="506.014,509.866" y="246.188" svg_rhmargin="514.366" style="fill:#000000;font-family:EHOOBT+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">11</text>
  <text svg_rhmargin="117.229" x="76.991,81.401,85.901,88.151,91.49,96.264,100.791,105.483,108.216,112.729,117.229" y="314.428" style="fill:#000000;font-family:EHOOBT+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">27 funding </text>
  <text x="146.121,152.563,157.063,159.313,162.652,167.425,171.952,176.645,179.377,183.891,188.391,190.641,195.168,199.708,202.705,204.955,209.455,212.154,216.681,220.823,223.82,226.07,231.313,235.933,240.129,244.678,248.712,251.248,255.337,257.839,260.089,264.615,269.156,272.153,274.403,278.903,281.601,286.129,290.27,293.267,295.517,299.119,303.688,308.295,312.917,317.457,320.835,323.337,325.587,332.097,336.261,339.762,342.012,345.1,349.238,353.32,357.354,359.818,364.211,368.336,372.836,375.086,379.557,384.057,386.307,390.503,394.961,399.461,401.711,405.754,410.281,412.979,417.498,422.038,425.035,427.285,433.973,436.432,439.13,443.63,445.88,448.967,452.956,457.525,461.731,464.779,469.279,471.529,474.163,478.663" y="314.428" svg_rhmargin="480.913" style="fill:#000000;font-family:CRUCZX+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">No funding nor other financial nor other support was received by any author with regard to </text>
  <text svg_rhmargin="433.179" x="191.609,194.307,199.018,201.594,205.095,207.345,210.926,215.478,219.04,221.683,225.807,232.929,236.963,239.678,242.143,246.139,248.389,251.474,255.505,260.193,262.645,266.683,272.628,274.878,277.128,283.821,286.464,288.966,291.216,295.257,299.784,302.482,307.001,311.541,314.714,318.215,320.465,325.032,329.169,333.063,335.615,339.822,342.909,346.905,349.155,353.68,358.18,360.43,364.525,369.07,373.889,379.037,381.502,385.583,388.085,390.335,394.684,397.681,399.931,402.664,407.151,409.793,413.935,417.022,421.151,424.714,427.399,430.929,433.179" y="314.428" style="fill:#000000;font-family:CRUCZX+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">this systematic review. All authors declare no conflict of interests. </text>
  <text x="507.94" y="314.428" svg_rhmargin="512.44" style="fill:#000000;font-family:EHOOBT+TimesNewRomanPSMT;font-size:9.0px;font-style:NORMAL;font-weight:normal;">1</text>
  <text x="72.866,77.775,81.826,86.305,88.612,92.164,94.164,98.164,100.164,103.816,107.862,112.31,115.256,117.707,122.132,126.603,130.484,133.054,136.992" y="82.71199999999999" svg_rhmargin="138.992" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPS-BoldMT;font-size:8.0px;font-style:NORMAL;font-weight:bold;">Table 2 continue-1.</text>
  <text y="82.71199999999999" svg_rhmargin="204.795" x="140.99,145.358,151.038,153.758,158.186,165.598,171.376,173.376,176.958,181.014,184.725,188.3,192.555,194.945,197.267,200.467,202.795" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:8.0px;font-style:NORMAL;font-weight:normal;">PRISMA checklist.</text>
  <text x="70.866,78.709,83.704,87.903,94.164,97.199,100.98" y="368.363" svg_rhmargin="105.259" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPS-BoldMT;font-size:11.0px;font-style:NORMAL;font-weight:bold;">Results</text>
  <text x="70.866,76.166,78.825,84.139,89.419,92.812,97.252,99.752,100.467,105.467,107.967,108.684,113.862,116.685,120.652,125.517,128.316,132.668,137.687,141.577,144.077,144.796,148.722,153.258,157.895,161.282,165.678,170.678,173.178,173.895,177.288,181.837,185.801,190.951,193.643,196.591,200.554,203.054,205.554,206.271,208.974,214.008,218.562,223.507,226.488,229.491,234.975,239.458,243.898,246.879,249.553,254.563,259.698,262.198,264.698,265.415,269.356,273.921,277.314,281.861,286.416" y="380.363" svg_rhmargin="291.416" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">Figure 1 displays search results, identification, screen</text>
  <text x="291.473" y="380.363" svg_rhmargin="294.803" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">-</text>
  <text x="70.866,73.867,78.842,83.842,86.342,86.982,90.157,95.157,98.487,100.987,101.627,105.961,108.87,111.528,116.702,119.496,124.423,127.303,130.212,132.904,136.001,141.001,143.501,144.141,148.768,153.759,158.759,161.259,161.899,164.901,169.916,174.2,176.935,182.089,185.913,188.586,193.596,198.596,201.096,201.736,206.528,209.858,212.358,212.998,217.973,223.017,227.882,230.792,233.489,237.971,242.411,245.392,248.065,253.075,258.214,262.104,264.604,265.244,269.755,274.765,279.904,283.728,286.43,291.473" y="392.363" svg_rhmargin="294.803" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">ing for eligibility and inclusion of publications consid-</text>
  <text x="70.866,75.431,78.824,83.369,88.369,90.559,93.734,98.734,102.064,104.254,108.193,113.212,117.133,120.033,124.579,132.454,136.894,139.876,142.573,147.013,149.203,152.596,157.036,162.209,164.893,169.341,176.561,178.751,183.378,188.369,193.369,195.559,203.339,207.816,210.837,215.311,218.71,223.338,228.434,232.94,235.652,240.671,244.494,247.316,251.198,253.698,255.888,262.626,267.626,275.43,280.474,285.112,288.736,291.473" y="404.363" svg_rhmargin="294.803" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">ered for systematic review and meta-analysis. Compari-</text>
  <text x="70.866,74.791,79.801,84.801,87.301,89.581,94.373,97.703,100.203,102.483,105.484,110.499,114.783,117.519,122.673,126.496,129.17,134.18,139.18,141.68,143.96,148.751,152.081,154.581,156.861,161.837,166.88,171.746,174.655,177.352,181.835,186.275,189.256,191.93,196.94,202.079,205.969,208.469,210.749,215.261,220.271,225.41,229.233,231.936,236.97,241.534,245.158,248.16,253.135,258.135,260.635,262.915,267.394,272.439,276.359,279.452,282.936,287.505,292.003,294.783" y="416.363" svg_rhmargin="297.283" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">son of inclusion of publications considering abstract </text>
  <text svg_rhmargin="244.441" x="70.866,75.493,80.59,85.096,87.807,92.826,96.65,99.472,103.362,105.862,106.792,110.185,114.625,119.465,124.0,128.507,131.209,135.755,140.755,143.255,144.185,148.625,151.125,152.05,157.195,161.668,166.75,171.795,176.269,179.314,184.289,188.796,191.531,196.546,200.986,203.486,204.416,209.208,212.538,215.038,215.968,220.808,223.129,228.019,232.681,237.681,240.181,241.111,244.441" y="428.363" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">analysis revealed a kappa-value of 0.932 ( </text>
  <text x="245.269" y="428.363" svg_rhmargin="250.269" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPS-ItalicMT;font-size:10.0px;font-style:ITALIC;font-weight:normal;">p</text>
  <text y="428.363" svg_rhmargin="297.31" x="253.699,259.338,261.838,262.768,267.608,269.943,275.149,280.355,284.844,289.178,292.31,294.81" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">&lt; 0.0001). </text>
  <text x="70.866,78.165,80.987,84.946,89.428,94.713,98.106,102.654,107.199,114.979,119.534,124.479,127.259,129.942,133.335,137.726,142.765,147.403,150.752,155.93,158.931,163.906,168.906,171.591,174.593,179.608,183.892,186.627,191.781,195.605,198.278,203.288,208.288,210.973,215.765,219.095,221.78,224.872,231.904,236.904,239.589,244.216,249.207,254.207,256.892,261.308,266.122,270.407,273.142,278.296,282.12,284.793,289.803,294.803" y="440.363" svg_rhmargin="297.303" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">Disagreement regarding inclusion of two and exclusion </text>
  <text x="70.866,75.658,78.988,81.378,86.388,91.388,95.828,98.218,103.193,108.237,113.102,116.011,118.709,123.191,127.631,130.612,133.285,138.295,143.434,147.324,149.714,156.911,161.499,165.389,167.779,171.172,175.722,179.646,184.481,187.178,192.018,196.563,201.563,203.953,208.445,212.079,214.979,219.544,222.874,225.264,228.942,234.092,236.991,239.771,242.161,245.061,249.477,254.549,257.329,259.719,264.347,269.443,273.949,276.661,281.68,285.503,288.326,292.289,294.789" y="452.363" svg_rhmargin="297.289" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">of one publications was resolved after full text analysis, </text>
  <text x="70.866,76.654,81.75,86.257,89.156,91.868,96.868,99.368,102.761,107.296,111.866,116.261,121.459,124.46,129.436,134.436,136.936,140.613,145.764,148.663,151.443,153.943,158.424,163.709,167.102,171.649,176.195,183.975,188.529,193.475,196.302" y="464.363" svg_rhmargin="198.802" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">finally reaching full agreement.</text>
  <text x="70.866,77.217,82.208,86.648,89.182,92.806,95.628,99.528,104.528,107.063,111.855,115.185,117.725,122.652,125.432,130.021,133.911,136.451,141.04,144.995,148.921,153.471,157.425,161.35,169.13,173.685,178.63,181.41,183.943,188.735,192.065,194.605,197.606,202.621,206.905,209.641,214.684,219.718,224.263,229.263,231.803,236.778,241.822,246.687,249.596,252.293,256.776,261.216,264.197,266.871,271.881,277.02,280.91,283.45,286.843,291.473" y="476.363" svg_rhmargin="294.803" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">The risk of bias assessment of included publications re-</text>
  <text x="70.866,75.706,80.241,84.748,87.45,91.996,96.996,98.946,103.573,108.573,110.523,115.354,120.194,124.758,128.242,132.749,135.648,138.428,140.378,145.576,148.234,153.438,158.438,160.388,164.012,166.835,170.734,175.734,177.684,182.476,185.806,187.756,192.196,195.275,198.367,201.991,204.682,207.664,210.337,215.347,220.347,222.297,227.224,230.004,234.592,238.482,240.432,245.059,250.05,255.05,257.0,260.393,264.992,270.09,275.09,278.811,281.792,284.793,289.768,294.768" y="488.363" svg_rhmargin="297.268" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">vealed an overall high risk of attrition bias and reporting </text>
  <text x="70.866,75.793,78.573,83.162,87.125,89.625,92.595,96.418,99.42,104.435,108.931,113.371,116.341,120.824,125.412,129.339,133.779,136.749,140.142,144.74,149.838,154.838,158.559,161.507,165.397,168.367,172.995,177.986,182.986,185.956,190.439,195.027,198.954,203.394,206.364,210.284,213.406,218.449,223.627,226.31,230.86,234.75,237.72,244.781,249.346,252.739,257.179,260.149,263.15,268.165,272.449,275.185,280.228,285.262,289.807,294.807" y="500.363" svg_rhmargin="297.307" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">bias, since case reports and case studies were included </text>
  <text x="70.866,78.741,83.258,86.259,91.456,94.167,98.518,101.018,103.372,110.714,114.669,118.595,123.145,127.1,131.024,138.804,143.359,148.304,151.084,153.436,158.228,161.558,163.912,167.396,172.024,177.015,182.04,187.04,194.82,197.172,201.099,205.644,210.697,215.712,220.267,225.282,229.778,234.218,236.571,241.513,246.067,251.067,255.632,259.116,263.556,266.538,269.211,274.221,279.356,281.856,284.21,288.717" y="512.363" svg_rhmargin="291.497" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">mainly. Assessment of random sequence generation, al</text>
  <text x="291.473" y="512.363" svg_rhmargin="294.803" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">-</text>
  <text x="70.866,73.559,78.652,83.135,87.575,90.557,93.23,98.24,103.24,105.74,106.98,111.492,116.502,121.517,126.013,130.549,135.055,138.066,145.846,150.4,155.345,158.255,160.755,163.255,164.495,169.36,172.27,175.271,180.262,185.44,188.441,193.416,198.416,200.916,202.156,206.948,210.278,212.778,214.018,219.063,223.701,227.422,230.403,233.1,237.54,240.28,245.325,249.953,254.898,257.845,261.735,264.235,265.481,270.07,273.96,276.46,277.706,284.767,289.101,292.0,294.78" y="524.363" svg_rhmargin="297.28" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">location concealment, blinding of participants as well </text>
  <text x="70.866,75.454,79.344,81.844,83.084,88.059,93.048,95.957,100.469,105.469,113.249,117.689,120.189,121.429,126.018,129.972,133.899,138.448,142.403,146.327,154.107,158.661,163.606,166.386,168.886,170.126,172.894,177.464,181.975,186.487,191.462,196.732,201.677,204.658,207.66,212.635,217.635,220.135,221.375,224.55,229.556,232.886,235.386,236.626,240.553,244.886,247.589,252.15,256.648,259.629,262.302,267.312,272.312,274.812,276.052,280.979,283.759,288.348,292.311,294.811" y="536.363" svg_rhmargin="297.311" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">as outcome assessment (accounting for selection bias, </text>
  <text x="70.866,75.965,80.53,84.111,87.286,92.286,96.012,103.887,108.515,113.53,118.026,122.466,124.409,129.336,132.116,136.705,140.595,142.545,147.172,152.163,157.163,159.108,164.142,168.619,171.52,176.081,180.579,183.56,186.233,191.243,196.243,198.188,203.115,205.895,210.483,213.818,217.148,219.093,226.289,230.878,234.768,236.718,241.709,246.671,249.451,251.394,255.866,260.948,265.813,268.722,271.42,275.902,280.381,285.246,287.948,292.307,294.807" y="548.363" svg_rhmargin="297.307" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">performance bias and detection bias) was not applicable. </text>
  <text x="70.866,78.121,82.561,85.582,90.022,92.832,99.894,104.459,107.852,112.292,115.102,118.495,122.972,126.065,129.689,132.372,136.812,141.652,146.197,151.197,154.007,157.656,161.024,166.024,173.804,176.614,179.615,184.63,188.914,191.65,196.693,201.727,206.272,211.272,214.082,219.057,224.101,228.966,231.875,234.572,239.055,243.495,246.477,249.15,254.16,259.299,263.189,265.999,270.627,275.618,280.618,283.428,286.43,291.473" y="560.363" svg_rhmargin="294.803" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">Data were retrieved from included publications and in-</text>
  <text x="70.866,74.041,79.041,82.767,90.643,95.083,98.064,100.738,105.748,110.748,113.268,118.278,123.278,125.798,129.191,133.528,136.732,141.297,144.69,149.244,154.259,158.756,163.196,165.696,168.216,172.136,175.258,180.301,185.329,190.329,192.849,195.947,201.285,206.384,210.824,213.324,215.844,220.797,226.057,233.804,238.883,243.448,246.778,249.298,254.09,257.42,259.94,262.931,270.734,275.599,278.398,283.025,287.97,290.917,294.807" y="572.363" svg_rhmargin="297.307" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">formation on reference, study type, number of implants </text>
  <text x="70.866,75.493,80.484,85.484,88.124,93.169,97.609,100.59,103.273,107.828,112.773,115.72,119.61,122.25,126.878,131.869,136.869,139.509,142.472,147.463,151.903,154.915,158.245,160.885,165.368,170.31,174.75,177.25,179.89,184.942,190.222,193.706,198.146,201.128,203.801,208.811,213.811,216.451,221.243,224.573,227.213,230.389,235.224,238.123,240.816,245.656,252.693,256.068,261.106,266.106,268.746,273.845,278.41,282.034,284.707,289.784,294.784" y="584.363" svg_rhmargin="297.284" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">and patients and their age, duration of follow-up period </text>
  <text x="70.866,75.454,79.344,82.064,89.125,93.459,96.358,99.138,101.858,106.447,110.337,113.057,116.048,123.851,128.716,131.515,136.142,141.087,143.867,146.587,150.551,155.831,159.557,164.73,167.426,172.401,176.908,179.688,182.408,185.892,190.332,193.233,197.782,201.672,204.392,209.03,212.423,216.863,219.583,222.492,225.315,229.235,232.136,236.681,241.681,244.401,247.402,252.402,255.122,260.569,265.048,269.913,272.615,277.055,279.775,284.574,287.074,289.794,294.794" y="596.363" svg_rhmargin="297.294" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">as well as implant survival rates are listed in Table 3, 3 </text>
  <text x="70.866,75.377,80.388,85.333,88.314,91.315,96.268,101.283,105.723,108.223,112.148,116.71,121.207,124.189,126.862,131.872,137.011,140.901,143.401,147.841,150.341,153.231,158.231,160.731,165.823" y="608.363" svg_rhmargin="168.323" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">continue sections a to d.</text>
  <text x="70.866,74.503,81.913,85.397,89.903,92.683,95.183,101.204,103.901,108.297,113.288,117.842,122.842,125.342,130.207,133.006,137.633,142.586,147.74" y="620.363" svg_rhmargin="151.63" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">-Oral Lichen planus</text>
  <text x="70.866,77.981,80.982,85.982,90.422,92.922,93.44,98.415,103.404,106.184,108.684,109.201,113.993,117.323,119.823,120.341,125.003,130.003,132.503,133.021,137.996,143.04,147.905,150.814,153.511,157.994,162.434,165.416,168.089,173.099,178.238,182.128,184.628,185.148,187.85,192.884,197.438,202.383,205.365,208.367,213.837,218.383,223.383,225.883,226.401,233.796,236.487,239.449,244.647,247.649,252.649,255.149,255.667,260.879,265.319,268.339,272.818,277.84,282.428,286.355,290.904,294.794" y="632.363" svg_rhmargin="297.294" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">Nine out of 32 publications identified within databases </text>
  <text x="70.866,78.646,83.124,85.904,88.404,89.394,92.356,97.347,101.787,104.287,105.277,108.278,113.293,117.578,120.313,125.467,129.29,131.964,136.974,141.974,144.474,145.464,150.029,153.653,156.344,159.244,163.809,167.433,170.213,174.653,177.153,178.143,180.898,184.073,189.048,194.328,197.658,200.158,201.148,205.63,210.219,214.145,218.585,221.085,222.075,225.469,230.067,235.165,240.165,243.886,246.833,250.797,253.297,255.797,256.787,259.75,265.069,268.462,273.009,277.449,279.949,280.939,284.332,288.81,291.473" y="644.363" svg_rhmargin="294.803" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">met the inclusion criteria (four case reports, three ret-</text>
  <text x="70.866,74.234,79.279,83.247,88.346,92.907,97.405,100.386,103.082,107.922,112.362,115.272,119.193,122.314,127.357,132.535,135.218,139.768,143.731,146.231,149.141,154.151,159.151,163.591,166.501,171.548,174.916,179.961,183.928,189.027,193.589,198.086,201.068,203.764,208.604,213.044,215.954,219.874,222.996,228.039,233.067,237.5,240.0,242.91,247.538,252.529,257.529,260.439,265.449,270.449,274.889,277.799,282.846,286.214,291.473" y="656.363" svg_rhmargin="294.803" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">rospective studies, one prospective study, and one pro-</text>
  <text x="70.866,74.834,79.933,84.494,88.992,91.973,94.669,99.509,103.949,106.449,108.169,112.68,117.69,122.635,125.728,129.096,133.931,136.83,139.532,144.078,149.078,151.578,153.298,157.219,160.34,165.383,170.411,174.961,178.092,180.592,183.092,184.812,192.067,196.507,199.527,203.967,206.467,208.187,212.979,216.309,218.809,220.529,225.361,230.361,232.861,234.581,237.785,242.331,250.206,254.712,257.415,261.855,264.355,266.075,270.702,275.693,280.693,283.193,284.913,289.769,294.769" y="668.363" svg_rhmargin="297.269" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">spective controlled study). Data of 73 female and 27 </text>
  <text x="70.866,78.741,83.248,85.95,90.39,92.89,93.94,98.985,103.425,106.406,109.09,113.644,118.589,121.536,125.426,127.926,128.976,132.939,138.074,141.603,144.807,149.371,152.995,155.996,160.972,165.972,168.472,169.522,173.172,176.54,181.535,189.315,191.815,192.865,197.754,203.82,208.82,211.32,212.37,219.432,223.996,227.389,231.829,234.329,235.379,238.772,243.249,246.342,249.966,252.649,257.089,261.929,266.474,271.474,273.974,275.024,278.673,282.041,287.041,294.821" y="680.363" svg_rhmargin="297.321" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">male patients suffering from oLp were retrieved from </text>
  <text x="70.866,73.828,78.819,83.369,87.295,91.735,94.125,99.332,102.333,107.333,111.773,114.163,119.138,124.182,129.047,131.956,134.654,139.136,143.576,146.558,149.231,154.241,159.38,163.27,165.666,168.454,172.38,176.928,181.368,183.758,189.205,193.683,198.548,201.251,205.691,208.081,213.081,215.471,219.398,223.96,228.457,231.438,234.112,239.122,244.122,246.512,250.487,253.618,256.118,258.508,263.847,267.215,272.215,279.995,282.385,285.348,290.339,294.779" y="692.363" svg_rhmargin="297.279" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">these nine publications (see Table 3 section a). From the </text>
  <text x="70.866,75.348,79.937,83.864,88.304,90.804,92.034,95.427,100.025,105.123,110.123,113.844,116.624,119.124,120.354,125.28,130.28,132.78,134.01,140.603,145.043,147.74,152.135,157.222,161.86,165.581,168.361,170.861,172.091,174.915,179.993,183.323,185.823,187.053,192.063,197.063,201.503,204.003,205.233,210.278,214.718,217.699,220.382,224.937,229.882,232.662,235.162,236.392,243.589,248.177,252.067,254.567,255.797,260.974,263.797,267.738,272.221,276.858,280.207,285.241,289.787,294.787" y="704.363" svg_rhmargin="297.287" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">case report by Reichart (6) one patient was discarded </text>
  <text x="70.866,75.918,80.933,85.373,87.873,90.764,95.764,98.264,103.534,108.877,114.244,119.235,124.075,131.585,136.585,139.085,144.138,149.417,152.902,157.342,160.323,162.997,168.007,173.007,175.507,180.299,183.629,186.129,189.304,194.139,197.038,199.731,204.571,211.608,214.983,220.021,225.021,227.521,232.62,237.185,240.809,243.482,248.559,253.651,256.151" y="716.363" svg_rhmargin="258.651" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">due to unknown duration of follow-up period. </text>
  <text x="70.866,78.161,82.71,86.678,91.605,94.296,97.196,101.636,104.136,105.926,108.724,113.293,117.679,122.679,125.179,126.969,131.761,135.091,137.591,139.381,144.415,148.893,151.913,156.429,159.31,162.151,166.041,168.541,170.331,173.724,178.116,183.155,187.792,191.142,196.319,199.321,204.296,209.296,211.796,213.586,218.634,222.002,227.047,230.967,233.93,238.91,243.987,249.012,254.022,258.968,261.949,264.646,269.086,271.586,273.376,276.469,279.862,284.397,288.837,291.473" y="728.363" svg_rhmargin="294.803" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">Despite lack of details regarding prosthodontic treat-</text>
  <text svg_rhmargin="297.292" x="70.866,78.646,83.201,88.146,90.926,93.426,95.869,99.044,104.044,107.374,109.874,112.319,117.364,121.804,124.785,127.468,132.023,136.968,139.615,142.945,145.445,147.89,152.89,156.22,158.72,161.165,164.157,171.96,176.825,179.623,184.251,189.196,191.843,195.232,200.254,204.843,208.769,213.315,218.315,220.815,223.26,227.887,232.983,237.49,240.201,245.22,249.044,251.866,255.756,258.256,260.706,263.707,268.707,271.207,273.652,277.577,282.572,290.352,294.792,297.292" y="367.847" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">ment for patient- or implant-based analysis in some </text>
  <text x="314.646,319.621,324.665,329.53,332.439,335.137,339.619,344.059,347.04,349.713,354.723,359.862,363.752,366.252,367.542,370.712,373.713,378.896,382.072,387.072,390.799,398.674,403.114,406.096,408.769,413.779,418.779,421.279,422.569,427.579,432.579,435.079,436.369,441.134,446.134,448.634,449.924,458.254,460.754,462.044,466.836,470.166,472.666,473.956,479.001,483.441,486.422,489.105,493.66,498.605,501.552,505.442,507.942,509.232,513.821,517.711,520.211,521.501,528.563,532.897,535.796,538.576" y="367.847" svg_rhmargin="541.076" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">publications (information on 38 % of patients as well </text>
  <text x="314.646,319.234,323.124,325.624,326.204,330.891,335.144,337.585,342.585,345.085,345.665,353.995,356.495,357.075,361.867,365.197,367.697,368.277,371.268,379.072,383.937,386.735,391.363,396.308,399.255,403.145,405.645,406.225,413.286,417.851,421.244,425.684,428.184,428.764,433.755,438.717,441.497,443.997,444.577,448.915,453.89,458.406,461.286,464.085,468.563,473.428,476.131,480.042,483.217,485.717,488.217,488.797,491.76,496.751,501.191,503.691,504.271,512.147,516.469,519.147,524.147,527.772,530.463,533.56,538.56" y="379.847" svg_rhmargin="541.06" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">as 37.8 % of implants were not available), the majority </text>
  <text x="314.646,319.438,322.768,325.268,325.778,330.823,335.263,338.245,340.928,345.482,350.427,353.375,357.265,359.765,360.275,363.229,368.309,373.149,375.666,380.666,383.166,383.676,391.591,394.921,397.421,397.931,402.559,407.55,412.55,415.05,415.56,418.551,426.354,431.219,434.017,438.645,443.59,446.537,450.427,452.927,453.437,456.391,460.827,465.33,467.692,472.692,475.192,475.702,483.617,486.947,489.447,489.957,493.35,497.899,501.867,506.966,511.527,516.025,519.006,521.703,526.543,530.876,533.587,538.587" y="391.847" svg_rhmargin="541.087" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">of patients (90.3 %) and implants (91.6 %) respectively </text>
  <text x="314.646,321.708,326.272,329.665,334.105,336.492,339.584,342.977,347.513,351.953,354.853,359.399,364.399,366.786,374.181,376.872,379.835,384.835,387.222,392.995,397.801,402.347,407.347,409.734,414.779,419.416,423.137,426.119,428.899,433.406,436.186,438.571,443.605,448.159,453.104,456.226,461.506,464.899,469.448,473.412,475.912,478.299,485.486,490.477,495.041,498.434,502.97,507.558,511.448,513.837,518.847,524.044,526.755,531.755,534.143,538.583" y="403.847" svg_rhmargin="541.083" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">were treated with fixed partial dentures, whereas only a </text>
  <text x="314.646,317.85,322.299,329.519,332.019,333.029,336.422,340.967,348.737,353.569,358.543,363.022,367.887,370.589,375.029,377.529,378.539,383.051,388.051,395.854,400.719,403.421,407.899,410.799,415.239,417.739,418.749,423.796,427.164,432.209,436.13,439.092,444.083,448.633,452.559,457.109,460.999,463.499,464.509,467.322,471.825,474.187,479.187,481.687,482.697,491.027,493.527,494.537,499.464,504.464,506.964,507.974,513.019,517.459,520.44,523.123,527.678,532.623,535.27" y="415.847" svg_rhmargin="538.6" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">few removable complete prostheses (1.6 % by patient-</text>
  <text x="314.646,318.039,322.373,325.173,329.617,332.518,337.063,342.063,344.583,349.211,354.202,359.202,361.722,366.775,368.747,373.747,376.267,384.597,387.117,392.044,397.044,399.564,402.555,410.355,415.22,418.02,422.647,427.591,430.239,433.589,436.982,441.315,444.115,448.559,451.46,456.005,461.005,463.525,468.153,473.249,477.755,480.466,485.486,489.31,492.132,495.467,498.797,501.317,505.944,510.936,515.935,518.455,524.228,529.034,533.58,538.58" y="427.847" svg_rhmargin="541.08" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">related and 2.1 % by implant-related analysis) and fixed </text>
  <text x="314.646,319.157,324.157,331.96,336.825,339.527,344.005,346.905,351.345,353.64,358.687,362.055,367.1,371.021,373.983,378.974,383.524,387.45,392.0,395.89,398.19,401.158,406.114,408.086,413.086,415.386,423.716,426.016,430.943,435.943,438.243,443.288,447.728,450.71,453.393,457.947,462.892,465.54,468.886,472.279,476.612,479.41,483.85,486.75,491.296,496.296,498.596,503.223,508.214,513.214,515.514,520.449,522.966,527.966,530.266,538.596" y="439.847" svg_rhmargin="541.096" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">complete prostheses (8.1 % by patient-related and 6.3 % </text>
  <text x="314.646,319.573,324.573,327.073,330.064,337.868,342.733,345.531,350.158,355.103,357.751,361.097,364.49,368.823,371.622,376.062,378.963,383.508,388.508,391.008,395.635,400.731,405.238,407.949,412.968,416.792,419.614,422.949,426.279,428.779,435.84,440.405,443.798,448.238,450.738,455.891,459.817,464.363,469.455,471.955" y="451.847" svg_rhmargin="474.455" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">by implant-related analysis) were used. </text>
  <text x="314.646,318.213,323.213,325.713,327.193,332.203,337.203,341.643,344.143,345.623,349.543,352.665,357.708,362.736,367.169,369.669,372.169,373.649,378.204,383.204,385.704,387.184,390.175,397.978,402.843,405.642,410.269,415.214,418.162,422.052,424.552,426.032,433.093,437.658,441.051,445.491,447.991,449.471,452.472,457.611,461.538,466.102,469.823,472.724,477.269,482.269,484.769,486.249,491.301,496.581,500.205,503.206,508.181,513.181,515.681,517.161,521.73,526.227,531.216,534.116,538.556" y="463.847" svg_rhmargin="541.056" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">In one study, 55 implants were inserted during acute </text>
  <text x="314.646,320.216,324.854,328.247,332.687,335.187,336.357,341.149,344.479,346.979,348.151,352.72,357.218,360.199,362.895,367.735,372.175,374.675,375.845,380.734,386.801,391.801,394.301,395.472,400.626,404.45,407.451,412.426,417.426,419.926,421.097,424.089,432.177,439.957,444.503,449.681,452.461,456.901,459.801,464.241,466.741,467.911,470.902,478.706,483.571,486.369,490.996,495.941,498.962,503.402,506.384,509.057,514.067,519.067,521.567,522.738,525.74,530.685,533.575,538.575" y="475.847" svg_rhmargin="541.075" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">flare of active oLp using immediate implantation into </text>
  <text x="314.646,317.608,322.599,327.039,329.539,331.623,335.548,340.641,345.026,349.919,354.397,357.177,359.677,361.76,365.724,370.768,375.813,379.739,384.285,389.338,394.353,398.907,403.852,406.694,409.405,414.405,416.905,418.99,422.165,427.0,429.9,432.593,437.433,444.828,447.829,452.804,457.804,460.304,462.389,466.805,471.877,474.969,478.453,483.023,487.52,490.501,493.175,498.185,503.185,505.685,507.77,510.583,514.844,519.844,522.344,524.429,527.421" y="487.847" svg_rhmargin="535.201" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">the socket subsequently following extraction (17 im</text>
  <text x="535.253" y="487.847" svg_rhmargin="538.583" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">-</text>
  <text x="314.646,319.511,322.309,326.937,331.882,334.829,338.164,341.494,343.994,346.094,351.094,354.424,356.924,359.024,362.016,370.104,377.884,382.43,387.608,390.388,394.828,397.729,402.169,404.669,406.769,409.463,414.485,419.079,424.257,427.259,432.233,437.233,439.733,441.833,449.603,454.68,459.714,464.154,466.654,468.754,471.751,476.026,481.026,483.526,485.626,488.617,496.42,501.285,504.084,508.711,513.656,516.604,519.938,523.113,525.613,528.113,530.213,535.213,538.543" y="499.847" svg_rhmargin="541.043" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">plants) or immediate loading mode (31 implants), or </text>
  <text x="314.646,319.723,324.685,327.647,332.647,335.287,339.798,344.808,349.799,354.977,357.668,360.65,363.323,368.333,373.472,377.362,380.008,382.962,387.962,390.602,393.593,401.397,406.262,409.06,413.688,418.633,421.58,424.914,428.046,430.546,433.186,437.968,442.968,445.608,448.599,456.403,461.267,464.066,468.693,473.638,476.586,480.476,483.122,486.461,490.978,493.858,496.561,501.106,506.106,508.746,511.778,516.763,521.763,524.403,527.394,535.253" y="511.847" svg_rhmargin="538.583" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">both conditions (9 implants). 42 implants failed (24 im-</text>
  <text x="314.646,322.426,326.972,332.15,334.93,339.37,342.27,346.603,349.315,354.315,356.815,359.105,361.799,366.821,371.415,376.449,380.995,386.19,388.69,391.19,393.48,398.48,400.98,403.27,406.261,414.35,422.13,426.675,431.853,434.633,439.073,441.974,446.307,449.018,454.018,456.518,458.808,461.809,466.948,470.875,475.439,479.16,482.061,486.606,491.567,494.897,497.397,499.687,504.314,509.305,514.305,516.805,519.095,526.157,530.721,534.114,538.554" y="523.847" svg_rhmargin="541.054" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">mediately loaded, 6 immediately inserted) and were </text>
  <text x="314.646,318.039,322.585,330.355,335.186,340.026,344.571,349.571,352.461,357.088,362.079,367.079,369.969,373.362,377.96,382.825,385.624,390.193,394.69,399.235,404.235,407.125,411.617,415.251,418.151,422.716,426.046,428.936,433.936,437.42,441.927,444.707,447.597,452.108,457.108,460.829,463.811,466.508,471.019,476.064,479.985,482.885,487.45,490.818,495.712,498.414,503.414,506.304,509.266,514.257,518.821,522.305,526.778,531.714,536.065,538.565" y="535.847" svg_rhmargin="541.065" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">removed and replaced after oral corticosteroid therapy. </text>
  <text x="314.646,321.761,326.771,331.771,336.211,338.711,343.501,346.831,349.331,352.294,357.285,361.725,364.225,367.616,372.215,377.08,379.878,384.447,388.944,393.489,398.489,400.989,403.981,411.784,416.649,419.447,424.075,429.02,431.967,435.857,438.357,441.699,446.215,449.096,451.798,456.343,461.343,463.843,466.656,471.149,475.803,478.935,481.435" y="547.847" svg_rhmargin="483.935" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">None of the replaced implants failed (10). </text>
  <text svg_rhmargin="410.995" x="314.646,318.213,323.213,325.713,326.383,329.346,334.337,338.777,341.277,341.941,345.862,348.983,354.026,359.054,364.054,366.554,367.224,372.152,377.152,379.652,380.322,387.842,393.049,395.741,398.862,404.055,408.495,410.995" y="559.847" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">In the study by Anitua </text>
  <text x="411.647,416.193,418.973,421.473,422.138,427.149,430.046" y="559.847" svg_rhmargin="432.546" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPS-ItalicMT;font-size:10.0px;font-style:ITALIC;font-weight:normal;">et al.</text>
  <text y="559.847" svg_rhmargin="541.091" x="435.717,438.53,442.753,447.087,450.262,452.762,455.262,455.932,459.808,464.789,469.789,473.51,476.29,478.79,479.455,482.446,490.25,495.114,497.913,502.54,507.485,510.433,514.323,516.823,517.493,522.531,527.531,530.031,530.701,533.591,538.591" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">(11), short implants up to </text>
  <text x="314.646,319.602,322.126,327.126,329.626,330.986,339.074,346.854,349.354,350.714,353.716,358.716,361.216,362.576,365.279,369.833,374.808,380.078,383.041,388.041,390.541,391.901,398.963,403.527,406.92,411.36,413.86,415.22,420.374,424.3,428.846,433.846,436.346,437.706,442.121,446.936,451.221,453.956,459.109,462.933,465.63,470.47,474.803,477.515,482.515,485.015,486.375,489.376,494.376,496.876,498.236,503.236,505.736,507.096,512.141,516.581,519.562,522.245,526.8,531.745,534.693,538.583" y="571.847" svg_rhmargin="541.083" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">8.5 mm in length were used exclusively in 8 patients </text>
  <text x="314.646,322.041,324.732,327.694,332.694,335.194,339.759,343.127,348.172,351.995,354.692,359.532,363.972,366.472,371.098,376.089,381.089,383.589,388.169,393.169,395.669,400.714,405.154,408.135,410.819,415.373,420.318,423.266,427.156,429.656,437.052,439.743,442.706,447.706,450.206,453.599,458.076,461.058,463.755,468.251,473.401,476.2,480.837,484.167,486.667,491.556,497.623,502.442" y="583.847" svg_rhmargin="504.942" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">with erosive and 15 patients with reticular oLp.</text>
  <text x="314.646,318.087,323.45,326.128,331.035,336.32,339.713,344.267,348.716,351.252,355.142,357.642,363.127,368.435,373.426,378.725,382.093,387.093,394.873" y="595.847" svg_rhmargin="399.313" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">-Sjgrens Syndrome</text>
  <text x="314.646,321.761,324.762,329.762,334.202,336.702,337.274,342.249,347.293,352.158,355.067,357.765,362.247,366.687,369.668,372.341,377.351,382.49,386.38,388.88,389.453,394.245,397.575,400.075,400.647,405.285,410.285,412.785,413.356,416.059,421.093,425.647,430.592,433.573,436.576,442.046,446.592,451.592,454.092,454.663,462.058,464.749,467.712,472.91,475.911,480.911,483.411,483.982,486.945,491.936,496.376,498.876,499.446,504.658,509.098,512.118,516.597,521.619,526.207,530.134,534.683,538.573" y="607.847" svg_rhmargin="541.073" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">Nine publications of 13 identified within the databases </text>
  <text x="314.646,322.426,326.904,329.684,332.434,335.397,340.388,344.828,347.578,350.579,355.594,359.879,362.614,367.768,371.592,374.265,379.275,384.275,387.025,391.59,395.214,397.905,400.805,405.37,408.994,411.774,416.214,418.964,422.139,427.139,430.469,433.219,436.181,441.172,445.612,448.362,452.302,457.321,461.241,464.142,468.687,476.562,481.002,483.983,486.68,491.12,493.87,497.263,501.703,506.876,509.56,514.008,521.228,523.978,528.606,533.597,538.597" y="619.847" svg_rhmargin="541.097" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">met the inclusion criteria for the systematic review and </text>
  <text x="314.646,318.039,322.479,327.318,331.854,336.361,339.063,343.608,348.608,351.108,352.368,357.58,362.02,365.04,369.48,371.98,373.24,378.031,381.361,383.861,385.121,389.933,394.933,397.433,398.693,401.898,406.443,414.318,418.825,421.527,425.967,428.467,429.727,434.315,438.205,440.705,441.965,449.026,453.36,456.259,459.039,461.539,462.799,467.387,471.277,473.777,475.037,480.037,482.537,483.797,491.672,496.179,498.881,503.321,505.821,507.081,512.126,516.566,519.548,522.231,526.785,531.73,534.678,538.568" y="631.847" svg_rhmargin="541.068" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">revealed data of 65 female as well as 6 male patients </text>
  <text x="314.646,318.61,323.745,327.273,330.477,335.041,338.665,341.667,346.642,351.642,354.142,355.356,359.005,362.373,367.373,375.153,377.653,378.866,384.229,386.876,392.474,394.974,397.474,398.688,402.082,406.643,411.139,415.579,418.275,423.448,426.449,431.425,436.425,438.925,440.139,443.13,450.934,455.798,458.596,463.224,468.169,470.816,474.21,479.257,482.625,487.67,491.591,494.553,499.544,504.021,507.003,509.7,514.14,516.64,517.853,521.246,525.686,530.773,535.253" y="643.847" svg_rhmargin="538.583" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">suffering from SjS, receiving implant-prosthetic reha-</text>
  <text x="314.646,319.573,322.453,325.363,328.054,331.074,335.514,338.495,341.168,346.178,351.178,353.678,355.118,357.906,361.73,364.716,369.716,372.216,373.656,378.139,382.727,386.654,391.094,393.594,395.029,398.422,403.021,408.119,413.119,416.84,419.787,423.677,426.177,427.617,432.244,437.235,442.235,444.735,446.175,451.185,456.185,460.625,463.125,464.565,469.047,473.636,477.562,482.002,484.502,485.942,489.868,494.433,498.057,500.74,505.29,509.253,511.753,514.2529999999999,515.693,519.086,523.564,526.656,530.024,535.253" y="655.847" svg_rhmargin="538.583" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">bilitation (six case reports and one case series, retro-</text>
  <text x="314.646,318.614,323.713,328.274,332.772,335.753,338.449,343.289,347.729,350.229,351.269,355.897,360.888,365.888,368.388,369.428,374.475,377.843,382.888,386.856,391.955,396.516,401.014,403.995,406.692,411.532,415.972,418.472,419.512,423.432,426.554,431.597,436.625,441.058,443.558,446.058,447.098,451.634,456.203,460.599,465.724,468.224,470.724,471.764,475.691,480.238,484.678,487.178,488.218,493.666,498.144,503.009,505.711,510.151,512.6510000000001,513.691,518.691,521.191,522.231,526.158,530.719,535.253" y="667.847" svg_rhmargin="538.583" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">spective and prospective study, each, see Table 3 sec-</text>
  <text x="314.646,317.627,320.301,325.311,330.311,332.611,337.054,340.185,342.685,344.985,352.239,356.679,359.699,364.139,366.439,369.832,374.223,379.262,383.9,387.249,392.427,395.428,400.403,405.403,407.703,412.881,415.703,419.624,422.716,426.34,429.133,434.108,439.097,442.079,444.752,449.762,454.762,457.062,461.854,465.184,467.484,470.581,475.919,481.018,485.458,487.758,492.549,495.879,498.179,503.226,506.594,511.639,515.56,518.523,523.514,528.064,531.887,534.71,538.6" y="679.847" svg_rhmargin="541.1" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">tion b). Data regarding distribution of type of prosthesis </text>
  <text x="314.646,321.708,326.272,329.665,334.105,336.875,341.212,346.187,350.704,353.584,356.382,360.861,365.726,368.428,372.868,375.638,379.031,383.364,386.163,390.603,393.503,398.049,403.049,405.819,408.709,413.709,416.479,419.165,423.512,430.732,433.502,436.383,444.259,448.871,454.04,456.92,459.82,462.618,467.058,469.828,474.455,479.446,484.446,487.216,492.216,495.546,498.315,506.19,510.818,515.809,520.987,523.781,528.646,531.348,535.26,538.59" y="691.847" svg_rhmargin="541.09" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">were available related to jaw (maxilla and or mandible) </text>
  <text x="314.646,319.656,324.853,327.564,331.915,334.415,336.96,341.96,346.96,349.505,352.192,356.539,363.759,367.649,370.199,377.261,381.825,385.218,389.658,392.202,395.294,398.687,403.223,407.663,410.563,415.109,420.201,422.701,425.246,432.492,435.822,438.366,441.329,446.32,450.869,454.796,459.236,461.736,464.281,469.475,474.348,476.71,481.71,484.254,492.584,495.129,502.191,506.755,510.148,514.588,517.132,520.224,523.617,528.154,532.594,535.253" y="703.847" svg_rhmargin="538.583" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">only. 92 jaws were treated. Of these, 44.6 % were treat-</text>
  <text x="314.646,319.192,324.192,326.592,331.746,335.569,338.57,343.545,348.545,350.945,353.936,361.739,366.604,369.403,374.03,378.975,381.622,384.969,388.362,392.839,395.859,400.376,403.377,408.377,412.923,417.923,420.323,423.716,428.261,436.032,440.863,445.838,450.316,455.181,457.884,462.324,464.724,469.236,474.236,482.039,486.904,489.606,494.084,496.984,501.424,503.824,508.858,513.411,518.357,521.479,526.759,530.152,534.701,538.591" y="715.847" svg_rhmargin="541.091" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">ed using implant-retained removable complete dentures </text>
  <text x="314.646,317.424,322.255,327.095,331.659,335.009,340.043,344.597,349.542,352.663,357.943,361.337,365.886,369.221,372.352,374.852,377.352,381.092,390.884,396.082,398.963,401.665,406.105,408.605,412.344,416.855,421.83,427.1,432.045,435.027,438.028,443.003,448.003,450.503,454.243,457.235,465.038,469.903,472.701,477.329,482.274,484.921,488.195,493.968,498.774,503.32,508.32,510.82,514.56,518.384,521.385,526.36,531.442,534.145,538.585" y="727.847" svg_rhmargin="541.085" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">(overdentures). While counting implant-fixed single </text>
  <text x="314.646,319.211,322.579,327.419,334.929,340.068,343.958,346.458,347.301,350.332,355.168,359.596,362.113,367.113,369.613,370.455,378.37,381.7,384.2,385.041,389.669,394.66,399.66,402.16,403.001,408.774,413.58,418.126,423.126,425.626,426.467,431.512,436.15,439.871,442.852,445.632,450.138,452.918,455.418,456.258,461.292,465.846,470.791,473.912,479.192,482.585,487.135,491.025,493.525,494.368,497.53,501.783,504.145,509.145,511.645,512.485,520.401,523.731,526.231,527.073,530.247,535.247,538.578" y="739.847" svg_rhmargin="541.078" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">crowns (29.3 %) and fixed partial dentures (7.6 %) for </text>
 </g>
</svg>
